UNSPSC 51294417: Aripiprazole lauroxil

This classification denotes an antipsychotic agent C36H51Cl2N3O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier B786J7A343, chemically known as (7-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butoxy)-2-oxo-3,4-dihydroquinolin-1(2h)-yl)methyl dodecanoate, but more generally known as aripiprazole lauroxil, which bears US NIH Compound Identifier 49831411. Most nations, for tariff and trade purposes, schedule aripiprazole lauroxil under HS 29337900 and SITC 51561.

As of Q4 2014, ARIPIPRAZOLE LAUROXIL remains US FDA's Preferred Term for this commodity. SMILES: CCCCCCCCCCCC(=O)OCN1C2CC(CCC2CCC1=O)OCCCCN3CCN(CC3)C4CCCC(C4CL)CL.

UNSPSC 51294417 Aripiprazole lauroxil is a Commodity code that the source materials show little relevant recent activity for — the single recent opportunity on record is Seminole County, Florida's IFB 60459723LAS, which solicits Naloxone and Safe Drug Deactivation Systems, not aripiprazole or related pharmaceutical compounds. Aripiprazole lauroxil is an atypical antipsychotic administered as a long-acting injectable; the Seminole County procurement targets opioid-overdose reversal agents and drug disposal systems, a distinct clinical application. State and local health departments, county community health systems, and public health authorities are the issuing bodies most likely to procure aripiprazole when needed — typically through mental health services programs, correctional health systems, or public safety initiatives — but the search results do not surface opportunities in those categories.

The mismatch between code and content suggests either a tagging error in the state and local procurement database or that aripiprazole demand at the state and local level has not generated recent formal solicitations under this specific code. Firms pursuing pharmaceutical-procurement opportunities with state and local health agencies should monitor RFP and IFB notices from state departments of health, county health and human services departments, and regional mental health authorities; confirm pharmaceutical codes against actual solicitation scope before responding; and verify that any quote engine or system tagging UNSPSC 51294417 reflects current demand for aripiprazole rather than neighboring therapeutic categories or formulations. No recent opportunities with decision-relevant detail are available under this code.